BIO-TECHNE Corp Selling, General and Administrative Expense
BIO-TECHNE Corp (TECH) reported Selling, General and Administrative Expense of $452.42 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-24
- BIO-TECHNE Corp selling, general and administrative expense for the quarter ending 2026-06-30 was $113.17M, a 42.45% decline year-over-year.
- BIO-TECHNE Corp selling, general and administrative expense for the quarter ending 2026-03-31 was $109.34M, a 27.72% decline year-over-year.
- BIO-TECHNE Corp selling, general and administrative expense for the quarter ending 2025-12-31 was $113.69M, a 6.39% decline year-over-year.
- BIO-TECHNE Corp selling, general and administrative expense for the quarter ending 2025-09-30 was $116.21M, a 2.47% decline year-over-year.
- BIO-TECHNE Corp selling, general and administrative expense for fiscal 2026 was $452.42M, a 23.13% decline from fiscal 2025.
- BIO-TECHNE Corp selling, general and administrative expense for fiscal 2025 was $588.52M, a 26.19% increase from fiscal 2024.
- BIO-TECHNE Corp selling, general and administrative expense for fiscal 2024 was $466.38M, a 23.26% increase from fiscal 2023.
- BIO-TECHNE Corp selling, general and administrative expense for fiscal 2023 was $378.38M, a 1.51% increase from fiscal 2022.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $113.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $222.51M derived: sum of 2 quarters · filed 2026-08-24 | $336.20M derived: sum of 3 quarters · filed 2026-08-24 | $452.42M 10-K · filed 2026-08-24 | |||
| 2026-03-31 | $109.34M 10-Q · filed 2026-05-06 | $223.03M derived: sum of 2 quarters · filed 2026-05-06 | $339.24M 10-Q · filed 2026-05-06 | $535.88M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2025-12-31 | $113.69M 10-Q · filed 2026-02-04 | $229.90M 10-Q · filed 2026-02-04 | $426.54M derived: sum of 3 quarters · filed 2026-08-24 | $577.81M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2025-09-30 | $116.21M 10-Q · filed 2025-11-05 | $312.85M derived: sum of 2 quarters · filed 2026-08-24 | $464.12M derived: sum of 3 quarters · filed 2026-08-24 | $585.57M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2025-06-30 | $196.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $347.91M derived: sum of 2 quarters · filed 2026-08-24 | $469.36M derived: sum of 3 quarters · filed 2026-08-24 | $588.52M 10-K · filed 2026-08-24 | |||
| 2025-03-31 | $151.27M 10-Q · filed 2026-05-06 | $272.72M derived: sum of 2 quarters · filed 2026-05-06 | $391.88M 10-Q · filed 2026-05-06 | $525.42M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2024-12-31 | $121.45M 10-Q · filed 2026-02-04 | $240.61M 10-Q · filed 2026-02-04 | $374.15M derived: sum of 3 quarters · filed 2026-08-24 | $485.99M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2024-09-30 | $119.16M 10-Q · filed 2025-11-05 | $252.70M derived: sum of 2 quarters · filed 2026-08-24 | $364.54M derived: sum of 3 quarters · filed 2026-08-24 | $480.20M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2024-06-30 | $133.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $245.38M derived: sum of 2 quarters · filed 2026-08-24 | $361.04M derived: sum of 3 quarters · filed 2026-08-24 | $466.38M 10-K · filed 2026-08-24 | |||
| 2024-03-31 | $111.84M 10-Q · filed 2025-05-08 | $227.51M derived: sum of 2 quarters · filed 2025-05-08 | $332.84M 10-Q · filed 2025-05-08 | $419.59M derived: sum of 4 quarters · filed 2025-08-22 | |||
| 2023-12-31 | $115.67M 10-Q · filed 2025-02-06 | $221.00M 10-Q · filed 2025-02-06 | $307.75M derived: sum of 3 quarters · filed 2025-08-22 | $406.99M derived: sum of 4 quarters · filed 2025-08-22 | |||
| 2023-09-30 | $105.33M 10-Q · filed 2024-11-05 | $192.09M derived: sum of 2 quarters · filed 2025-08-22 | $291.32M derived: sum of 3 quarters · filed 2025-08-22 | $384.33M derived: sum of 4 quarters · filed 2025-08-22 | |||
| 2023-06-30 | $86.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | $185.99M derived: sum of 2 quarters · filed 2025-08-22 | $279.00M derived: sum of 3 quarters · filed 2025-08-22 | $378.38M 10-K · filed 2025-08-22 | |||
| 2023-03-31 | $99.24M 10-Q · filed 2024-05-06 | $192.25M derived: sum of 2 quarters · filed 2024-05-06 | $291.62M 10-Q · filed 2024-05-06 | $388.25M derived: sum of 4 quarters · filed 2024-08-22 | |||
| 2022-12-31 | $93.01M 10-Q · filed 2024-02-07 | $192.39M 10-Q · filed 2024-02-07 | $289.01M derived: sum of 3 quarters · filed 2024-08-22 | $378.28M derived: sum of 4 quarters · filed 2024-08-22 | |||
| 2022-09-30 | $99.38M 10-Q · filed 2023-11-07 | $196.00M derived: sum of 2 quarters · filed 2024-08-22 | $285.27M derived: sum of 3 quarters · filed 2024-08-22 | $385.97M derived: sum of 4 quarters · filed 2024-08-22 | |||
| 2022-06-30 | $96.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22 | $185.90M derived: sum of 2 quarters · filed 2024-08-22 | $286.59M derived: sum of 3 quarters · filed 2024-08-22 | $372.77M 10-K · filed 2024-08-22 | |||
| 2022-03-31 | $89.27M 10-Q · filed 2023-05-08 | $189.96M derived: sum of 2 quarters · filed 2023-05-08 | $276.14M 10-Q · filed 2023-05-08 | $362.78M derived: sum of 4 quarters · filed 2023-08-23 | |||
| 2021-12-31 | $100.69M 10-Q · filed 2023-02-07 | $186.87M 10-Q · filed 2023-02-07 | $273.51M derived: sum of 3 quarters · filed 2023-08-23 | $356.11M derived: sum of 4 quarters · filed 2023-08-23 | |||
| 2021-09-30 | $86.17M 10-Q · filed 2022-11-07 | $172.82M derived: sum of 2 quarters · filed 2023-08-23 | $255.41M derived: sum of 3 quarters · filed 2023-08-23 | $338.53M derived: sum of 4 quarters · filed 2023-08-23 | |||
| 2021-06-30 | $86.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $169.24M derived: sum of 2 quarters · filed 2023-08-23 | $252.35M derived: sum of 3 quarters · filed 2023-08-23 | $324.95M 10-K · filed 2023-08-23 | |||
| 2021-03-31 | $82.60M 10-Q · filed 2022-05-09 | $165.71M derived: sum of 2 quarters · filed 2022-05-09 | $238.31M 10-Q · filed 2022-05-09 | $295.54M derived: sum of 4 quarters · filed 2022-08-24 | |||
| 2020-12-31 | $83.12M 10-Q · filed 2022-02-07 | $155.71M 10-Q · filed 2022-02-07 | $212.94M derived: sum of 3 quarters · filed 2022-08-24 | $279.26M derived: sum of 4 quarters · filed 2022-08-24 | |||
| 2020-09-30 | $72.60M 10-Q · filed 2021-11-08 | $129.82M derived: sum of 2 quarters · filed 2022-08-24 | $196.14M derived: sum of 3 quarters · filed 2022-08-24 | $264.17M derived: sum of 4 quarters · filed 2022-08-24 | |||
| 2020-06-30 | $57.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-24 | $123.54M derived: sum of 2 quarters · filed 2022-08-24 | $191.57M derived: sum of 3 quarters · filed 2022-08-24 | $260.58M 10-K · filed 2022-08-24 | |||
| 2020-03-31 | $66.32M 10-Q · filed 2021-05-07 | $134.35M derived: sum of 2 quarters · filed 2021-05-07 | $203.36M 10-Q · filed 2021-05-07 | $272.10M derived: sum of 4 quarters · filed 2021-08-25 | |||
| 2019-12-31 | $68.03M 10-Q · filed 2021-02-08 | $137.04M 10-Q · filed 2021-02-08 | $205.78M derived: sum of 3 quarters · filed 2021-08-25 | $270.75M derived: sum of 4 quarters · filed 2021-08-25 | |||
| 2019-09-30 | $69.01M 10-Q · filed 2020-11-09 | $137.75M derived: sum of 2 quarters · filed 2021-08-25 | $202.72M derived: sum of 3 quarters · filed 2021-08-25 | $266.32M derived: sum of 4 quarters · filed 2021-08-25 | |||
| 2019-06-30 | $68.74M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25 | $133.71M derived: sum of 2 quarters · filed 2021-08-25 | $197.31M derived: sum of 3 quarters · filed 2021-08-25 | $264.36M 10-K · filed 2021-08-25 | |||
| 2019-03-31 | $64.97M 10-Q · filed 2020-05-11 | $128.57M derived: sum of 2 quarters · filed 2020-05-11 | $195.62M 10-Q · filed 2020-05-11 | $260.91M derived: sum of 4 quarters · filed 2020-08-26 | |||
| 2018-12-31 | $63.60M 10-Q · filed 2020-02-06 | $130.66M 10-Q · filed 2020-02-06 | $195.94M derived: sum of 3 quarters · filed 2020-08-26 | $249.23M derived: sum of 4 quarters · filed 2020-08-26 | |||
| 2018-09-30 | $67.05M 10-Q · filed 2019-11-06 | $132.34M derived: sum of 2 quarters · filed 2020-08-26 | $185.62M derived: sum of 3 quarters · filed 2020-08-26 | $249.40M derived: sum of 4 quarters · filed 2020-08-26 | |||
| 2018-06-30 | $65.29M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-26 | $118.57M derived: sum of 2 quarters · filed 2020-08-26 | $182.35M derived: sum of 3 quarters · filed 2020-08-26 | $240.64M 10-K · filed 2020-08-26 | |||
| 2018-03-31 | $53.28M 10-Q · filed 2019-05-07 | $117.06M derived: sum of 2 quarters · filed 2019-05-07 | $175.35M 10-Q · filed 2019-05-07 | $223.98M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2017-12-31 | $63.77M 10-Q · filed 2019-02-07 | $122.06M 10-Q · filed 2019-02-07 | $170.69M derived: sum of 3 quarters · filed 2019-11-06 | $220.10M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2017-09-30 | $58.29M 10-Q · filed 2018-11-07 | $106.92M derived: sum of 2 quarters · filed 2019-11-06 | $156.33M derived: sum of 3 quarters · filed 2019-11-06 | $213.31M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2017-06-30 | $48.63M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06 | $98.04M derived: sum of 2 quarters · filed 2019-11-06 | $155.02M derived: sum of 3 quarters · filed 2019-11-06 | $200.44M 10-K/A · filed 2019-11-06 | |||
| 2017-03-31 | $49.41M 10-Q · filed 2018-05-09 | $48.11M 10-Q · filed 2017-05-10 | $106.39M derived: sum of 2 quarters · filed 2018-05-09 | $151.81M 10-Q · filed 2018-05-09 | $150.03M 10-Q · filed 2017-05-10 | $189.85M derived: sum of 4 quarters · filed 2018-08-27 | |
| 2016-12-31 | $56.98M 10-Q · filed 2018-02-08 | $55.66M 10-Q · filed 2017-02-09 | $102.41M 10-Q · filed 2018-02-08 | $101.92M 10-Q · filed 2017-02-09 | $140.44M derived: sum of 3 quarters · filed 2018-08-27 | $175.66M derived: sum of 4 quarters · filed 2018-08-27 | |
| 2016-09-30 | $45.42M 10-Q · filed 2017-11-09 | $46.26M 10-Q · filed 2016-11-09 | $83.46M derived: sum of 2 quarters · filed 2018-08-27 | $118.68M derived: sum of 3 quarters · filed 2018-08-27 | $153.26M derived: sum of 4 quarters · filed 2018-08-27 | ||
| 2016-06-30 | $38.04M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-27 | $73.25M derived: sum of 2 quarters · filed 2018-08-27 | $107.84M derived: sum of 3 quarters · filed 2018-08-27 | $140.88M 10-K · filed 2018-08-27 | |||
| 2016-03-31 | $35.22M 10-Q · filed 2017-05-10 | $69.80M derived: sum of 2 quarters · filed 2017-05-10 | $102.84M 10-Q · filed 2017-05-10 | $133.32M derived: sum of 4 quarters · filed 2017-09-07 | |||
| 2015-12-31 | $34.59M 10-Q · filed 2017-02-09 | $67.63M 10-Q · filed 2017-02-09 | $98.10M derived: sum of 3 quarters · filed 2017-09-07 | $127.19M derived: sum of 4 quarters · filed 2017-09-07 | |||
| 2015-09-30 | $33.04M 10-Q · filed 2016-11-09 | $63.51M derived: sum of 2 quarters · filed 2017-09-07 | $92.60M derived: sum of 3 quarters · filed 2017-09-07 | $123.74M derived: sum of 4 quarters · filed 2017-09-07 | |||
| 2015-06-30 | $30.47M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $59.56M derived: sum of 2 quarters · filed 2017-09-07 | $90.70M derived: sum of 3 quarters · filed 2017-09-07 | $119.40M 10-K · filed 2017-09-07 | |||
| 2015-03-31 | $29.09M 10-Q · filed 2016-05-10 | $60.23M derived: sum of 2 quarters · filed 2016-05-10 | $88.93M 10-Q · filed 2016-05-10 | $106.03M derived: sum of 4 quarters · filed 2016-08-29 | |||
| 2014-12-31 | $31.14M 10-Q · filed 2016-02-09 | $59.84M 10-Q · filed 2016-02-09 | $76.94M derived: sum of 3 quarters · filed 2016-08-29 | $91.61M derived: sum of 4 quarters · filed 2016-08-29 | |||
| 2014-09-30 | $28.70M 10-Q · filed 2015-11-09 | $45.80M derived: sum of 2 quarters · filed 2016-08-29 | $60.47M derived: sum of 3 quarters · filed 2016-08-29 | $75.40M derived: sum of 4 quarters · filed 2016-08-29 | |||
| 2014-06-30 | $17.10M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29 | $31.77M derived: sum of 2 quarters · filed 2016-08-29 | $46.70M derived: sum of 3 quarters · filed 2016-08-29 | $60.72M 10-K · filed 2016-08-29 | |||
| 2014-03-31 | $14.67M 10-Q · filed 2015-05-11 | $29.59M derived: sum of 2 quarters · filed 2015-05-11 | $43.61M 10-Q · filed 2015-05-11 | $55.73M derived: sum of 4 quarters · filed 2015-08-31 | |||
| 2013-12-31 | $14.93M 10-Q · filed 2015-02-09 | $28.95M 10-Q · filed 2015-02-09 | $41.06M derived: sum of 3 quarters · filed 2015-08-31 | $51.05M derived: sum of 4 quarters · filed 2015-08-31 | |||
| 2013-09-30 | $14.02M 10-Q · filed 2014-11-10 | $26.14M derived: sum of 2 quarters · filed 2015-08-31 | $36.12M derived: sum of 3 quarters · filed 2015-08-31 | $47.08M derived: sum of 4 quarters · filed 2015-08-31 | |||
| 2013-06-30 | $12.12M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31 | $22.10M derived: sum of 2 quarters · filed 2015-08-31 | $33.06M derived: sum of 3 quarters · filed 2015-08-31 | $43.38M 10-K · filed 2015-08-31 | |||
| 2013-03-31 | $9.98M 10-Q · filed 2014-05-12 | $20.94M derived: sum of 2 quarters · filed 2014-05-12 | $31.27M 10-Q · filed 2014-05-12 | $41.63M derived: sum of 4 quarters · filed 2014-08-29 | |||
| 2012-12-31 | $10.96M 10-Q · filed 2014-02-04 | $21.28M 10-Q · filed 2014-02-04 | $31.64M derived: sum of 3 quarters · filed 2014-08-29 | $41.54M derived: sum of 4 quarters · filed 2014-08-29 | |||
| 2012-09-30 | $10.33M 10-Q · filed 2013-11-12 | $20.69M derived: sum of 2 quarters · filed 2014-08-29 | $30.59M derived: sum of 3 quarters · filed 2014-08-29 | $41.24M derived: sum of 4 quarters · filed 2014-08-29 | |||
| 2012-06-30 | $10.36M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-29 | $20.26M derived: sum of 2 quarters · filed 2014-08-29 | $30.91M derived: sum of 3 quarters · filed 2014-08-29 | $41.68M 10-K · filed 2014-08-29 | |||
| 2012-03-31 | $9.90M 10-Q · filed 2013-05-10 | $20.55M derived: sum of 2 quarters · filed 2013-05-10 | $31.32M 10-Q · filed 2013-05-10 | $41.88M derived: sum of 4 quarters · filed 2013-08-29 | |||
| 2011-12-31 | $10.65M 10-Q · filed 2013-02-11 | $21.42M 10-Q · filed 2013-02-11 | $31.99M derived: sum of 3 quarters · filed 2013-08-29 | $41.28M derived: sum of 4 quarters · filed 2013-08-29 | |||
| 2011-09-30 | $10.77M 10-Q · filed 2012-11-09 | $21.34M derived: sum of 2 quarters · filed 2013-08-29 | $30.63M derived: sum of 3 quarters · filed 2013-08-29 | $39.06M derived: sum of 4 quarters · filed 2013-08-29 | |||
| 2011-06-30 | $10.56M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29 | $19.86M derived: sum of 2 quarters · filed 2013-08-29 | $28.28M derived: sum of 3 quarters · filed 2013-08-29 | $35.90M 10-K · filed 2013-08-29 | |||
| 2011-03-31 | $9.29M 10-Q · filed 2012-05-10 | $9.23M 10-Q · filed 2011-05-10 | $17.72M derived: sum of 2 quarters · filed 2012-05-10 | $25.34M 10-Q · filed 2012-05-10 | $25.15M 10-Q · filed 2011-05-10 | $33.32M derived: sum of 4 quarters · filed 2012-08-29 | |
| 2010-12-31 | $8.43M 10-Q · filed 2012-02-07 | $8.37M 10-Q · filed 2011-02-09 | $16.04M 10-Q · filed 2012-02-07 | $15.92M 10-Q · filed 2011-02-09 | $24.03M derived: sum of 3 quarters · filed 2012-08-29 | $31.70M derived: sum of 4 quarters · filed 2012-08-29 | |
| 2010-09-30 | $7.61M 10-Q · filed 2011-11-09 | $7.55M 10-Q · filed 2010-11-09 | $15.60M derived: sum of 2 quarters · filed 2012-08-29 | $23.27M derived: sum of 3 quarters · filed 2012-08-29 | $32.27M derived: sum of 4 quarters · filed 2012-08-29 | ||
| 2010-06-30 | $7.99M derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-29 | $15.65M derived: sum of 2 quarters · filed 2012-08-29 | $24.66M derived: sum of 3 quarters · filed 2012-08-29 | $32.70M 10-K · filed 2012-08-29 | |||
| 2010-03-31 | $7.67M 10-Q · filed 2011-05-10 | $16.67M derived: sum of 2 quarters · filed 2011-05-10 | $24.71M 10-Q · filed 2011-05-10 | ||||
| 2009-12-31 | $9.01M 10-Q · filed 2011-02-09 | $17.05M 10-Q · filed 2011-02-09 | |||||
| 2009-09-30 | $8.04M 10-Q · filed 2010-11-09 | ||||||
| 2009-06-30 | $33.69M 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |